Truccazzano, Italy

Federico Gennari

This inventor holds 12 USPTO granted patents. Top assignees: Bioresearch, Inc., Nb Jackets De Puerto Rico. Active years: 1984-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 7

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1984-1993

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Federico Gennari: Innovator in Pharmaceutical Composition

Introduction

Federico Gennari is a notable inventor based in Truccazzano, Italy. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing stable pharmaceutical compositions that have practical applications in medicine.

Latest Patents

Gennari's latest patents include a stable pharmaceutical composition of alkaline or alkaline earth 5-methyl. This invention details a method for preparing d,1-5-methyltetrahydrofolic acid and its salts. The process involves the reduction of folic acid with sodium borohydride, followed by the methylation of the resulting tetrahydrofolic acid with aqueous solutions of formaldehyde and sodium borohydride in an inert atmosphere. Another significant patent is for stable sulpho-adenosyl-L-methionine (SAMe) salts, which are particularly suitable for various applications. This invention relates to new stable SAMe salts and their production process.

Career Highlights

Throughout his career, Federico Gennari has worked with various companies, including Bioresearch S.p.a. and Nb Jackets de Puerto Rico. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Federico Gennari's contributions to pharmaceutical compositions demonstrate his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective and stable solutions for healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…